
Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

